 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/30/2018 |
$90.26 |
$94.27 |
$89.87 |
$94.27 |
12.03M | | 12/03/2018 |
$94.32 |
$94.72 |
$92.82 |
$93.66 |
6.67M | | 12/04/2018 |
$93.92 |
$94.98 |
$90.40 |
$90.55 |
7.01M | | 12/06/2018 |
$89.70 |
$90.48 |
$87.17 |
$90.33 |
8.73M | | 12/07/2018 |
$89.93 |
$90.00 |
$86.37 |
$86.96 |
6.62M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on November 30, 2018, ABBV opened at $90.26, traded as high as $94.27 and as low as $89.87, and closed at $94.27. Trading volume was a total of 12.03M shares. On December 03, 2018, ABBV opened at $94.32, traded as high as $94.72 and as low as $92.82, and closed at $93.66. Trading volume was a total of 6.67M shares. On December 04, 2018, ABBV opened at $93.92, traded as high as $94.98 and as low as $90.40, and closed at $90.55. Trading volume was a total of 7.01M shares. On December 06, 2018, ABBV opened at $89.70, traded as high as $90.48 and as low as $87.17, and closed at $90.33. Trading volume was a total of 8.73M shares. On December 07, 2018, ABBV opened at $89.93, traded as high as $90.00 and as low as $86.37, and closed at $86.96. Trading volume was a total of 6.62M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
12/07/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.96 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
353.61 |
|
| Dividends reinvested/share: |
$13.71 |
|
| Total return: |
207.50% |
|
| Average Annual Total Return: |
20.85% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$30,750.10 |
|
| Years: |
5.93 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
12/07/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.96 |
|
| Dividends collected/share: |
$13.71 |
|
| Total return: |
186.65% |
|
| Average Annual Total Return: |
19.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$28,668.10 |
|
| Years: |
5.93 |
|
|
|
| Date |
Close |
| 11/30/2018 | $94.27 | | 12/03/2018 | $93.66 | | 12/04/2018 | $90.55 | | 12/06/2018 | $90.33 | | 12/07/2018 | $86.96 |
|
|
